Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James B Dale

Showing results (21-30 of 68) with videos related to

Pageof 7
Sort By:
Infection and Immunity|March 16, 2002
Antibodies against a synthetic peptide of SagA neutralize the cytolytic activity of streptolysin S from group A streptococciJames B Dale, Edna Y Chiang, David L Hasty, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 20, 2006
Temporal changes in streptococcal M protein types and the near-disappearance of acute rheumatic fever in the United StatesStanford T Shulman, Gene Stollerman, Bernard Beall, et al.
Vaccine|August 18, 2023
Structure-guided design of a broadly cross-reactive multivalent group a streptococcal vaccineJames B Dale, Michelle P Aranha, Thomas A Penfound, et al.
The Journal of Infectious Diseases|April 7, 2010
The NH(2)-terminal region of Streptococcus pyogenes M5 protein confers protection against degradation by proteases and enhances mucosal colonization of miceThomas A Penfound, Itzhak Ofek, Harry S Courtney, et al.
Msphere|July 17, 2020
Systematic Review and Meta-analysis of the Prevalence of Group A Streptococcal <i>emm</i> Clusters in Africa To Inform Vaccine DevelopmentTaariq Salie, Kelin Engel, Annesinah Moloi, et al.
European Journal of Pediatrics|September 25, 2008
Age-associated differences in prevalence of group A streptococcal type-specific M antibodies in childrenPreeti Jaggi, James B Dale, Edna Chiang, et al.
Clinical and Diagnostic Laboratory Immunology|July 9, 2005
Multivalent group A streptococcal vaccine elicits bactericidal antibodies against variant M subtypesJames B Dale, Thomas Penfound, Edna Y Chiang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 14, 2014
Added value of the emm-cluster typing system to analyze group A Streptococcus epidemiology in high-income settingsStanford T Shulman, Robert R Tanz, James B Dale, et al.
The Pediatric Infectious Disease Journal|August 13, 2013
Group A streptococcal emm type prevalence among symptomatic children in Cape Town and potential vaccine coverageMark E Engel, Babu Muhamed, Andrew C Whitelaw, et al.
Clinical and Experimental Vaccine Research|February 8, 2017
Trivalent M-related protein as a component of next generation group A streptococcal vaccinesHarry S Courtney, Shannon E Niedermeyer, Thomas A Penfound, et al.
Pageof 7

Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
Infection and Immunity|March 16, 2002
Antibodies against a synthetic peptide of SagA neutralize the cytolytic activity of streptolysin S from group A streptococciJames B Dale, Edna Y Chiang, David L Hasty, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 20, 2006
Temporal changes in streptococcal M protein types and the near-disappearance of acute rheumatic fever in the United StatesStanford T Shulman, Gene Stollerman, Bernard Beall, et al.
Vaccine|August 18, 2023
Structure-guided design of a broadly cross-reactive multivalent group a streptococcal vaccineJames B Dale, Michelle P Aranha, Thomas A Penfound, et al.
The Journal of Infectious Diseases|April 7, 2010
The NH(2)-terminal region of Streptococcus pyogenes M5 protein confers protection against degradation by proteases and enhances mucosal colonization of miceThomas A Penfound, Itzhak Ofek, Harry S Courtney, et al.
Msphere|July 17, 2020
Systematic Review and Meta-analysis of the Prevalence of Group A Streptococcal <i>emm</i> Clusters in Africa To Inform Vaccine DevelopmentTaariq Salie, Kelin Engel, Annesinah Moloi, et al.
European Journal of Pediatrics|September 25, 2008
Age-associated differences in prevalence of group A streptococcal type-specific M antibodies in childrenPreeti Jaggi, James B Dale, Edna Chiang, et al.
Clinical and Diagnostic Laboratory Immunology|July 9, 2005
Multivalent group A streptococcal vaccine elicits bactericidal antibodies against variant M subtypesJames B Dale, Thomas Penfound, Edna Y Chiang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 14, 2014
Added value of the emm-cluster typing system to analyze group A Streptococcus epidemiology in high-income settingsStanford T Shulman, Robert R Tanz, James B Dale, et al.
The Pediatric Infectious Disease Journal|August 13, 2013
Group A streptococcal emm type prevalence among symptomatic children in Cape Town and potential vaccine coverageMark E Engel, Babu Muhamed, Andrew C Whitelaw, et al.
Clinical and Experimental Vaccine Research|February 8, 2017
Trivalent M-related protein as a component of next generation group A streptococcal vaccinesHarry S Courtney, Shannon E Niedermeyer, Thomas A Penfound, et al.
Pageof 7